Andere Sprachen PureTech Health plc

Aktien

A14VK6

GB00BY2Z0H74

PRTC

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:01 31.05.2024			% 5 Tage	% 1. Jan.
234 ^GBX	+0.65%		+2.86%	+20.49%

29.05.	PureTech's Ankili soll von Virtual Therapeutics ubernommen werden	AN
21.05.	Das von PureTech gegründete Unternehmen Vedanta beginnt mit Studien für das Medikament VE303 gegen Darmbakterien	AN

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PureTech's Ankili to be acquired by Virtual Therapeutics	29.05.
PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug	21.05.
PureTech Health Launches $100 Million Share Repurchase	20.05.
PureTech Health launches USD100 million buyback programme	20.05.
PureTech Health plc announces an Equity Buyback for 33,500,000 shares, representing 12.37% for $100 million.	20.05.
PureTech Health plc authorizes a Buyback Plan.	20.05.
EARNINGS AND TRADING: Asiamet Resources declares special dividend	10.05.
EARNINGS AND TRADING: Asiamet Resources declares special dividend	10.05.
Seaport Therapeutics Announces Board of Directors Changes and Makes Key Executive Appointments	07.05.
Transcript : PureTech Health plc, 2023 Earnings Call, Apr 25, 2024	25.04.
PureTech touts "momentum" as grants shrivel but annual loss narrows	25.04.
Miner Anglo American reviews takeover bid from rival BHP	25.04.
Miner Anglo American eyes rival BHP takeover	25.04.
Correction: Earnings Flash (PRTC.L) PURETECH HEALTH Posts FY23 Loss $-0.24	25.04.
Earnings Flash (PRTC.L) PURETECH HEALTH Reports FY23 Revenue $3.3M	25.04.
PureTech Health plc Reports Earnings Results for the Full Year Ended December 31, 2023	25.04.
EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling	16.04.
PureTech Health plc Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis	16.04.
US FDA hands fast track to PureTech head and neck cancer treatment	11.04.
PureTech Health plc Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers	11.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PureTech Health plc

Aktien

A14VK6

GB00BY2Z0H74

PRTC

Andere Sprachen

Filter